Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing β-catenin

International Journal of Cancer

Volumn 101, Issue 4, 2002, Pages 301-310

  Wang, Hanlin L ^a   Wang, Julia ^a   Xiao, Shu Yuan ^b   Haydon, Rex ^c   Stoiber, Debra ^b   He, Tong Chuan ^b   Bissonnette, Marc ^b   Hart, John ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

catenin; C Myc; Colorectal cancer; Cyclin D1; Fra 1; Gene expression

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR FRA 1;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; BETA CATENIN; BLOTTING, WESTERN; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYCLIN D1; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 0036783391     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10630     Document Type: Article

References (59)

1. APC mutations occur early during colorectal tumorigenesis
2. Lessons from hereditary colorectal cancer
3. Biology of the adenomatous polyposis coli tumor suppressor
4. Colon cancer: Molecular biology of the APC protein
5. The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
6. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
7. The role of β-catenin in cell adhesion, signal transduction, and cancer
8. Control of β-catenin signaling in tumor development
9. Human cancer syndromes: Clues to the origin and nature of cancer
10. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma
11. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
12. TCF transcription factors: Molecular switches in carcinogenesis
13. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
14. Identification of c-MYC as a target of the APC pathway
15. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
16. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
17. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
18. c-Myc target genes involved in cell growth, apoptosis, and metabolism
19. Cell cycle: On target with Myc
20. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli
21. MYC oncogenes and human neoplastic disease
22. Cancer cell cycles
23. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
24. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells
25. Expression of cyclins D1 and E in human colon adenocarcinomas
26. Fra-1: A serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen
27. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: Transcription factor AP-1 is comprised of multiple protein complexes
28. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product
29. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells
30. Expression of Jun family members in human colorectal adenocarcinoma
31. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma
32. Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis IV: Study of c-myc, c-fos and p53 mRNA expression
33. Detection of c-myc oncogene product in colonic polyps and carcinomas
34. Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis
35. c-myc oncogene expression in colorectal cancer
36. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas
37. Cellular localisation of c-Myc product in human colorectal epithelial neoplasia
38. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors
39. c-myc protein distribution: Neoplastic tissues of the human colon
40. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene
41. Differential expression of c-myc gene and c-fos gene in premalignant tissues from patients with familial polyposis coli
42. Expression of c-myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential
43. Expression of the myc gene family in different stages of human colorectal cancer
44. Expression of c-myc and c-fos mRNA in colorectal carcinoma in man
45. Increased levels of phorbin, c-myc, and ornithin decarboxylase RNAs in human colon cancer
46. Over-expression of the c-myc proto-oncogene in colorectal carcinoma
47. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
48. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
49. Frequent deletions and mutations of the β-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma
50. γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin
51. The expression of E-cadherin and catenins in sporadic colorectal carcinoma
52. Suppression of tumorigenicity by plakoglobin: An augmenting effect of N-cadherin
53. Mechanisms of apoptosis by c-Myc
54. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways
55. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals
56. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: Transrepression correlates with acceleration of apoptosis
57. Genetic dissection of c-myc apoptotic pathways
58. Experimental yellow fever virus infection in golden hamster (Mesocricetus auratus). II. Pathology
59. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity